Genaconazole

N/A

Report date: 2022/05/16 18:00:14
NME

Base Information

Drug NameGenaconazole
Drug Alias Name京纳康唑Sch-42427 (RR-isomer)Sch-42426 (SS-isomer)SM-9164 (RR -isomer)Sch-39304 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsHIV InfectionsMeningitis, CryptococcalMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Dainippon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo DainipponMerck Sharp & Dohme CorpNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV InfectionsMeningitis, CryptococcalMycoses

Other Information

ATC CodeN/A
Related LinksN/A